首页> 外文期刊>The Internet Journal of Microbiology >Evaluation of the antibacterial activity and toxicity of Myrciaria caulifloria methanolic leaf and fruit extracts
【24h】

Evaluation of the antibacterial activity and toxicity of Myrciaria caulifloria methanolic leaf and fruit extracts

机译:桃花心木甲醇叶和果实提取物的抗菌活性和毒性评价

获取原文
       

摘要

Methanol extracts from M. caulifloria leaves and fruit were tested for antimicrobial activity and toxicity in vitro. M. caulifloria leaf extract inhibited the growth of 9 of the 14 bacteria tested (64%) whilst the fruit extract inhibited the growth of 11 of the 14 bacteria tested (79%). Both Gram-positive and Gram-negative bacterial growth were inhibited by M. caulifloria leaf and flower extracts. 7 of the 10 Gram-negative bacteria (70%) and 2 of the 4 Gram-positive bacteria (50%) tested had their growth inhibited by M. caulifloria leaf extract whereas the fruit extract inhibited 7 of the 10 Gram-negative bacteria (70%) and 100% of the Gram-positive bacteria tested. M. caulifloria leaf extract proved to be toxic in the Artemia fransiscana bioassay with 24, 48 and 72h LC50’s of 232.9 ± 36.3 μg/ml, 169.1 ± 11.5 μg/ml and 128.1 ± 5.6 μg/ml respectively, making it more toxic than Mevinphos (24, 48 and 72h LC50’s 1346.0 ± 78.2 μg/ml, 505.3 ± 37.7 μg/ml, 103.9 ± 12.8) at all time points except 72h but less toxic than potassium dichromate (24, 48 and 72h LC50’s 86.3 ± 5.1 μg/ml, 80.4 ± 4.3 μg/ml, 77.9 ± 4.9). M. caulifloria fruit extract was non-toxic in the Artemia fransiscana bioassay indicating its potential as an antibacterial agent for medicinal use. Introduction Bacterial resistance to currently used antibiotics is becoming a concern to public health (Monroe and Polk, 2000). The development of bacterial super resistant strains is resulting in currently used antibiotic agents failing to end many bacterial infections. For this reason the search is ongoing for new antimicrobial agents, either by the design and synthesis of new agents, or through the search of natural sources for as yet undiscovered antimicrobial agents (Bhavnani and Ballow, 2000). The antiseptic qualities of medicinal plants have been long recognised. Recently there has been a revival of interest in herbal medications (Chariandy et al., 1999) due to a perception that there is a lower incidence of adverse reactions to plant preparations compared to synthetic pharmaceuticals. Myrciaria cauliflora (Mart.) O.Berg. (commonly known as jaboticaba) is a small evergreen tree of the family Myrtaceae. It is native to Brazil and the West Indies. M. cauliflora is grown extensively in Minas Gerais region near Rio de Janiero in Southern Brazil for the small (3-4cm diameter) tough skinned purple grape-like fruit it grows along its branches. The fruit has a thick purple skin covering a sweet, white or rosy pink gelatinous flesh containing 1 – 4 seeds. The fruit have a pleasant flavour and are commonly eaten fresh or used to produce jams, strong wines, and liqueurs. M. cauliflora also has a history of use as a traditional medicine for the treatment of numerous ailments. The skin is used to produce an astringent decoction which has been used in the treatment of a wide variety of ailments including diarrhoea, asthma and haemoptysis (Morton, 1987). Gargling the decoction has also been used to relieve chronic inflammation of the tonsils (Morton, 1987). Despite its range of traditional medicinal uses, the phytochemistry and therapeutic potential of M. cauliflora has not been extensively studied. M. cauliflora has been reported to contain tannins (Morton, 1987), cyanidin 3-glucoside (Einbond et al., 2004) and peonidin 3-glucoside and its aglycone (Trevisan et al., 1972). In his recent doctoral thesis, Reynertson (2007) identified a novel depside (jaboticabin) and 16 other known compounds from crude methanolic extracts from M. cauliflora fruit. This report highlighted the two depsides jaboticabin and 2-O-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetic acid as being of particular therapeutic potential due to their ability to inhibit cytokine production, their cytotoxicity towards HT29 and HCT116 colon cancer cell lines and their antioxidant activity. Surprisingly, the antiseptic properties of M. cauliflora remain largely unstudied. The antibacterial and antifungal properties of other m
机译:测试了花椰菜叶和果实中的甲醇提取物的体外抗菌活性和毒性。花椰菜叶提取物抑制了测试的14种细菌中的9种(64%)的生长,而水果提取物抑制了测试的14种细菌中的11种(79%)的生长。花椰菜分枝杆菌的叶和花提取物抑制革兰氏阳性和革兰氏阴性细菌的生长。测试的10种革兰氏阴性细菌中有7种(70%)和4种革兰氏阳性细菌中的2种(50%)被花椰菜叶提取物抑制了生长,而水果提取物抑制了10种革兰氏阴性细菌中的7种( 70%)和100%的革兰氏阳性菌。花椰菜分枝杆菌叶提取物在苦参碱生物测定中被证明具有毒性,24、48和72h LC50分别为232.9±36.3μg/ ml,169.1±11.5μg/ ml和128.1±5.6μg/ ml,使其比Mevinphos更具毒性(24、48和72h LC50为1346.0±78.2μg/ ml,505.3±37.7μg/ ml,103.9±12.8),但72h除外,但毒性低于重铬酸钾(24、48和72h LC50为86.3±5.1μg/ ml ,80.4±4.3μg/ ml,77.9±4.9)。花椰分枝杆菌果实提取物在苦参碱生物测定中无毒,表明其有可能用作药用抗菌剂。引言对目前使用的抗生素的细菌耐药性正成为公共卫生的关注点(Monroe and Polk,2000)。细菌超抗性菌株的发展导致当前使用的抗生素无法终止许多细菌感染。因此,无论是通过设计或合成新的抗微生物剂,还是通过寻找尚未发现的抗微生物剂的天然来源,都在寻找新的抗微生物剂(Bhavnani和Ballow,2000)。药用植物的防腐特性早已得到认可。最近,由于人们认为与合成药物相比,对植物制剂的不良反应发生率较低,人们对草药的兴趣有所恢复(Chariandy等,1999)。桃金娘(Marty Cauliflora)(Mart。) (通常被称为jaboticaba)是桃金娘科的一棵常绿小树。它原产于巴西和西印度群岛。花椰菜M. cauliflora在巴西南部里约热内卢附近的米纳斯吉拉斯州的米纳斯地区广泛种植,其小(直径3-4厘米)坚韧的表皮紫色葡萄状水果沿着其分支生长。果实有一层厚厚的紫色皮,覆盖着甜的,白色或玫瑰色的粉红色胶状果肉,内含1-4种种子。水果味道宜人,通常新鲜食用或用于制作果酱,烈性酒和利口酒。花椰菜还具有作为治疗多种疾病的传统药物的使用历史。皮肤用于产生收敛剂,该收敛剂已经用于治疗多种疾病,包括腹泻,哮喘和咯血(Morton,1987)。漱口水还被用于缓解扁桃体的慢性炎症(Morton,1987)。尽管其具有传统医学用途的范围,但尚未广泛研究花椰菜的植物化学和治疗潜力。据报道,花椰菜含单宁(Morton,1987),花青素3-葡糖苷(Einbond等,2004)和子苷3-葡糖苷及其糖苷(Trevisan等,1972)。 Reynertson(2007)在他最近的博士学位论文中,从花椰菜果实的粗甲醇提取物中鉴定了一种新型的Depside(茉莉花香素)和其他16种已知化合物。该报告强调了这两种独立的茉莉花香素和2-O-(3,4-二羟基苯甲酰基)-2,4,6-三羟基苯基乙酸由于具有抑制细胞因子产生的能力,对HT29和HCT116结肠的细胞毒性而具有特别的治疗潜力。癌细胞系及其抗氧化活性。令人惊讶的是,花椰菜的抗菌特性在很大程度上尚未得到研究。其他产品的抗菌和抗真菌特性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号